Ohtuvayre

Generic: ensifentrine

3MG/2.5ML — Suspension

PHOSPHODIESTERASE 3 & 4 (PDE3 & PDE4) INHIBITORS

Also known as: ensifentrine OHTUVAYRE SUSP 3MG/2.5ML

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 13 hours, 24 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
BCBS Federal Standard Option 2026 Tier 3 - Non-Preferred Brand None
BCBS Federal Basic Option 2026 Tier 3 - Non-Preferred Brand None
Source: CMS QHP JSON  ·  Formulary date: Mar 18, 2026  ·  Checked: 13 hours, 24 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
HealthSpring TotalCare (HMO D-SNP) Tier 5 - Specialty 150 per 30 days PA | QL
HealthSpring TotalCare Plus (HMO D-SNP) Tier 5 - Specialty 150 per 30 days PA | QL
HealthSpring Preferred (HMO) Tier 5 - Specialty 150 per 30 days PA | QL
HealthSpring Preferred Select (HMO) Tier 5 - Specialty 150 per 30 days PA | QL
HealthSpring Preferred Savings (HMO) Tier 5 - Specialty 150 per 30 days PA | QL
HealthSpring Preferred Plus (HMO) Tier 5 - Specialty 150 per 30 days PA | QL
HealthSpring True Choice (PPO) Tier 5 - Specialty 150 per 30 days PA | QL
Source: Excel (XLSX)  ·  Formulary date: Jan 5, 2026  ·  Checked: 13 hours, 24 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026
via ensifentrine
Tier 3 - Non-Formulary PA
Something not right?